These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 1240143)
1. Time-limited phototherapy of term newborns in ABO hemolytic disease and hyperbilirubinaemia. Rosta J; Makoi Z; Békefi D; Várady J Perinat Med; 1975; 3(3):198-203. PubMed ID: 1240143 [TBL] [Abstract][Full Text] [Related]
2. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility. Sarici SU; Yurdakök M; Serdar MA; Oran O; Erdem G; Tekinalp G; Yiğit S Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726 [TBL] [Abstract][Full Text] [Related]
3. Sn-Mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion. Kappas A; Drummond GS; Munson DP; Marshall JR Pediatrics; 2001 Dec; 108(6):1374-7. PubMed ID: 11731664 [TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn. Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442 [TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn. Nasseri F; Mamouri GA; Babaei H Saudi Med J; 2006 Dec; 27(12):1827-30. PubMed ID: 17143357 [TBL] [Abstract][Full Text] [Related]
7. Risk factors for readmission for hyperbilirubinemia in neonates with ABO hemolytic disease: a single-center retrospective cohort study. Xu C; Bao Y; He Y; Wu M; Zhu J J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2238106. PubMed ID: 37487760 [TBL] [Abstract][Full Text] [Related]
8. [Positive Coomb's test in newborns; causes and clinical consequences Summary of cases diagnosed in the Blood Bank in the years 2005 to 2012]. Kristinsdottir T; Kjartansson S; Hardardottir H; Jonsson T; Halldorsdottir AM Laeknabladid; 2016 Jul; 102(7-8):326-31. PubMed ID: 27531851 [TBL] [Abstract][Full Text] [Related]
11. Morbidity of ABO haemolytic disease in the newborn. Bhat YR; Kumar CG Paediatr Int Child Health; 2012 May; 32(2):93-6. PubMed ID: 22595217 [TBL] [Abstract][Full Text] [Related]
12. [Fototherapy of neonatal hyperbilirubinemia. Results of its clinical application (author's transl)]. Hohenauer L; Haschke F; Gerstl JW Klin Padiatr; 1976 Jul; 188(4):314-9. PubMed ID: 988423 [TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin in the management of hemolytic disease of the newborn. Mundy CA Neonatal Netw; 2005; 24(6):17-24. PubMed ID: 16383181 [TBL] [Abstract][Full Text] [Related]
14. Jaundice: a 10 year review of 41,000 live born infants. Palmer DC; Drew JH Aust Paediatr J; 1983 Jun; 19(2):86-9. PubMed ID: 6414449 [TBL] [Abstract][Full Text] [Related]
15. [Remote monitoring of neonatal jaundice in newborns with ABO hemolytic disease]. Xu C; Bao Y; Zhu J; Teng Y; He Y; Cheng K; Ji F; Wu M Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 49(5):651-655. PubMed ID: 33210495 [TBL] [Abstract][Full Text] [Related]
16. Prediction of ABO hemolytic disease of the newborn using pre- and perinatal quantification of maternal anti-A/anti-B IgG titer. Krog GR; Donneborg ML; Hansen BM; Lorenzen H; Clausen FB; Jensen KV; Kjærbye-Thygesen A; Albertsen P; Ebbesen F; Bergholt T; Smed MK; Dziegiel MH Pediatr Res; 2021 Jul; 90(1):74-81. PubMed ID: 33173174 [TBL] [Abstract][Full Text] [Related]
17. Routine administration of intravenous calcium during exchange blood transfusion for treatment of severe neonatal hyperbilirubinaemia: a systematic review of quantitative evidence protocol. Orimadegun AE; Akingbola TS JBI Database System Rev Implement Rep; 2015 Jan; 13(1):134-45. PubMed ID: 26447014 [TBL] [Abstract][Full Text] [Related]
18. The value of first-day bilirubin measurement in predicting the development of significant hyperbilirubinemia in healthy term newborns. Alpay F; Sarici SU; Tosuncuk HD; Serdar MA; Inanç N; Gökçay E Pediatrics; 2000 Aug; 106(2):E16. PubMed ID: 10920172 [TBL] [Abstract][Full Text] [Related]
19. [Hemolytic disease of the newborn due to ABO incompatibility (author's transl)]. Fischer K; Poschmann A; Grundmann A Z Geburtshilfe Perinatol; 1977 Aug; 181(4):227-40. PubMed ID: 410177 [TBL] [Abstract][Full Text] [Related]
20. ABO hemolytic disease: a comparative study of clinical severity and delayed anemia. Kanto WP; Marino B; Godwin AS; Bunyapen C Pediatrics; 1978 Sep; 62(3):365-9. PubMed ID: 568235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]